News
NIH’s Steven Ferguson will be speaking at the Licensing Executives Society (LES) upcoming virtual seminar titled Industry, Universities, and Government – How to Work Together Through Contracts. This seminar will take place on June 25, 2024 from 10am-1pm EST. “The interface between institutions doing
![blank new placeholder image](/themes/custom/ott/images/news-card-placeholder.png)
This technology identifies a new form of Cushing syndrome, "isolated micronodular adrenocortical disease" (iMAD), classified as a rare disease, as well as the role of PDE11A gene in this disease. Particular sequence variants of the PDE11A gene associated with abnormal or altered function of the gene
![blank new placeholder image](/themes/custom/ott/images/news-card-placeholder.png)
A new cancer vaccine developed by Merck makes use of a novel disease prevention strategy to protect against cervical cancer. The vaccine is based on research conducted at the NIH. Cervical cancer is the second most common form of cancer deaths in women worldwide. Each year roughly 233,000 women die
![blank new placeholder image](/themes/custom/ott/images/news-card-placeholder.png)
Six NIH technologies that have been developed into commercial products are featured in Federal Technology Transfer 2006, a new booklet from the Federal Laboratory Consortium (FLC). The booklet is a compilation of some of the most promising projects from FLC's member laboratories and agencies during